Although an increased CD4+/CD8+ cell infiltration of the tumor stroma has previously been shown to represent a favorable prognostic factor in NSCLC [5], ineffective therapeutic approaches with IL-2 [6] and interferon [7] have led to the conclusion that NSCLC is non-immunogenic. This evidence concerns the gene IL2 and non-small cell lung carcinoma.